DUBLIN--(BUSINESS WIRE)--The "Aortic Stent Graft Market - Global Outlook and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The aortic stent graft market is expected to reach over $3.7 billion by 2024, growing at an impressive CAGR of around 6% during 2018-2024.
The aortic stent graft market is expected to benefit from the following trends:
- High popularity of FEVAR procedure
- Emergence of EVAS procedure
- High preference for MI aneurysm repair
- Growth in mergers and acquisitions
The commercialization of innovative grafts such as fenestrated aortic stent grafts has further broadened the treatment options for aortic aneurysm, thereby increasing the market for aortic stent grafts. With recent advancements in fenestrated stent graft technology, endovascular approaches are becoming options to treat patients with complex anatomies. Hence, the rise in the number of aortic aneurysm patient population is expected to contribute to the overall growth of the global aortic stent graft market. Also, the increasing number of government screening programs for the elderly population to detect aortic aneurysm has provided immense growth opportunities for the global aortic stent graft market.
The research report on the aortic stent graft market covers sizing and forecast, market share, industry trends, growth drivers, and vendor analysis. The market study includes insights on segmentation by aneurysm (abdominal aortic aneurysm and thoracic aortic aneurysm), end-users (hospitals and ASCs), and geography (North America, Europe, APAC, Latin America, and MEA).
The study considers the present scenario of the market and its market dynamics for the period 2018-2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspect of the market. The report profiles and examines leading companies and other prominent companies operating in the aortic stent graft market.
Key Vendor Analysis
The aortic stent graft market is highly consolidated with major players accounting for dominant shares. Key companies have a wide geographical presence, diversified product portfolio, and a strong focus on innovation and research activities. Although major players dominate the market, few emerging companies are gaining traction with their innovative grafts and technologies.
Several leading players are focusing on implementing strategies such as product launches, innovative marketing, and promotional activities, strategic acquisitions, increase in R&D investment, and strengthen their distribution networks to enhance their market share and presence in the aortic stent graft market.
- Cook Medical
- L. Gore & Associates
- MicroPort Scientific
- Bentley Innomed
- Cardinal Health
- LeMaitre Vascular
For more information about this report visit https://www.researchandmarkets.com/r/j504rs